Cite
Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma.
MLA
Lu, Chun‐Wei, et al. “Zinc Deficiency Associated with Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Patients with Lung Adenocarcinoma.” Journal of the European Academy of Dermatology & Venereology, vol. 37, no. 2, Feb. 2023, pp. 328–39. EBSCOhost, https://doi.org/10.1111/jdv.18703.
APA
Lu, C., Pang, J. S., Ko, Y., Chang, C., Wang, C., Chen, W., Chen, C., Hui, R. C., Hung, S., Lu, L., Lu, K. L., Wang, C., Wu, C., Hsu, P., Fang, Y., Li, S., Ko, H., Tseng, L., Shih, F., & Chen, M. (2023). Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma. Journal of the European Academy of Dermatology & Venereology, 37(2), 328–339. https://doi.org/10.1111/jdv.18703
Chicago
Lu, Chun‐Wei, Jong‐Hwei Su Pang, Yu‐Shien Ko, Chih‐Jung Chang, Chuang‐Wei Wang, Wei‐Ti Chen, Chun‐Bing Chen, et al. 2023. “Zinc Deficiency Associated with Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Patients with Lung Adenocarcinoma.” Journal of the European Academy of Dermatology & Venereology 37 (2): 328–39. doi:10.1111/jdv.18703.